Delivery Order SPE2DB24D2101-SPE2DB25FKNZP
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 15, 2025, for the supply of Trulicity 1.5 mg/0.5 ml pen injectors, with a ceiling value of $1,801.80 and an ultimate completion date of September 16, 2025. This is a firm fixed-price delivery order with no set-aside designation, meaning it was competitively awarded. The contract is being performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $2,137.38 for Trulicity 1.5 mg/0.5 ml pen injectors on August 21, 2025, with completion scheduled for August 22, 2025. This competitively awarded, firm fixed-price contract is classified as a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. The pharmaceutical products...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $5,654.56 for Trulicity 1.5 mg/0.5 ml pen injectors on July 30, 2025, with completion scheduled for July 31, 2025. This firm fixed-price contract, executed without a set-aside designation, represents a competitively awarded transaction under AmerisourceBergen's broader pharmaceutical supply relationship with the federal government. The product will be delivered to the company's facility in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order valued at $1,169.99 to AmerisourceBergen Drug Corp for the supply of Trulicity 0.75 mg/0.5 mL pen injectors on June 26, 2025. This competitively awarded, firm fixed-price delivery order represents a non-set-aside procurement and is scheduled for completion by June 27, 2025, with performance taking place at the contractor's facility in Conshohocken, Pennsylvania. Trulicity is a branded diabetes medication used to improve blood sugar control in...
- The Defense Logistics Agency awarded a $5,648.01 firm fixed price delivery order to AmerisourceBergen Drug Corp on August 26, 2025, for the supply of Trulicity 4.5 mg/0.5 mL pen injectors with an ultimate completion date of August 27, 2025. This non-set-aside contract represents a single delivery order executed through AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated as SPE2DX and valued at $999,999,999.00 through December 2026. The place...
- The Defense Logistics Agency awarded a $12,054.36 delivery order to AmerisourceBergen Drug Corp for Trulicity 4.5 mg/0.5 ml pen injectors on July 24, 2025, with completion scheduled for July 25, 2025. This competitively awarded, firm fixed-price contract involves no set-aside designation and specifies performance at AmerisourceBergen's facility in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support...
- The Defense Logistics Agency (DLA) awarded a $4,413.01 delivery order to AmerisourceBergen Drug Corp for Trulicity 1.5 mg/0.5 mL pen injectors (0.5 mL units) on August 11, 2025, with completion scheduled for August 12, 2025. This is a firm fixed-price, non-set-aside contract performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a small-value transaction within the pharmaceutical distribution portfolio that AmerisourceBergen...
- The Defense Logistics Agency awarded a $3,003.00 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Trulicity 0.75 mg/0.5 ml pen injectors on August 29, 2025, with completion scheduled for September 2, 2025. This non-set-aside contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and running through December 2026. The delivery order will be fulfilled at the contractor's...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 9, 2025, for the supply of Trulicity 0.75 mg/0.5 ml pen injectors valued at $2,702.70, with completion scheduled for September 10, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order is executed under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $1,277.30 for Trulicity 1.5 mg/0.5 mL pen injections on April 24, 2025, with an ultimate completion date of April 25, 2025. This is a firm fixed-price delivery order with no set-aside designation, competitively awarded under AmerisourceBergen's existing pharmaceutical supply contract vehicle. The product will be delivered to the company's facility in Conshohocken, Pennsylvania, where AmerisourceBergen...
- SPE2DB24D2101Indefinite Delivery Contract
- SPE2DB24D2101-SPE2DB25FKNZPDelivery Order
The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $6,006.00 for Trulicity 0.75 mg/0.5 ml pen injectors on August 27, 2025, with completion scheduled for August 28, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and represents a small-value transaction within the company's broader federal pharmaceutical supply portfolio. The product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is executed under AmerisourceBergen's Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which carries a potential value of $999,999,999.00 through December 2026. The parent IDC serves as a comprehensive global pharmaceutical support vehicle enabling AmerisourceBergen to supply a wide range of medications and medical supplies to support military healthcare programs worldwide. Trulicity, a diabetes medication, exemplifies the specialty pharmaceuticals that AmerisourceBergen routinely provides to support Defense Health Agency and other federal healthcare system requirements through this flexible contract mechanism.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $6.0k | 8/27/25 |